IGF2BP3 Produkte
(Insulin-Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte IGF2BP3 Kategorien
IGF2BP3 Antikörper
High quality antibodies with extensive validation data.
IGF2BP3 ELISA Kits
Reliable ELISA kits for a wide range of species.
IGF2BP3 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene IGF2BP3 Antikörper
- (5)
- (5)
- (4)
Empfohlene IGF2BP3 ELISA Kits
- (1)
- (1)
- (1)
Empfohlene IGF2BP3 Proteine
- (1)
- (1)
- (1)
Neueste Publikationen zu unseren IGF2BP3 Produkten
: "Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer." in: Anticancer research, Vol. 37, Issue 1, pp. 135-142, (2017) (PubMed).: "The Zinc-Finger Antiviral Protein ZAP Inhibits LINE and Alu Retrotransposition." in: PLoS genetics, Vol. 11, Issue 5, pp. e1005121, (2015) (PubMed).
: "Enhanced IMP3 Expression Activates NF-?B Pathway and Promotes Renal Cell Carcinoma Progression." in: PLoS ONE, Vol. 10, Issue 4, pp. e0124338, (2015) (PubMed).
: "Prognostic value of tissue and circulating levels of IMP3 in prostate cancer." in: International journal of cancer. Journal international du cancer, Vol. 135, Issue 7, pp. 1596-604, (2014) (PubMed).
: "IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer." in: Oncotarget, Vol. 5, Issue 16, pp. 6832-45, (2014) (PubMed).
: "IMP3 predicts aggressive superficial urothelial carcinoma of the bladder." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, Issue 6, pp. 1701-6, (2008) (PubMed).
Synonyme und alternative Namen zu IGF2BP3
insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3), insulin-like growth factor 2 mRNA binding protein 3 (Igf2bp3), insulin like growth factor 2 mRNA binding protein 3 (igf2bp3), insulin-like growth factor 2 mRNA binding protein 3 (igf2bp3), insulin like growth factor 2 mRNA binding protein 3 (Igf2bp3), insulin like growth factor 2 mRNA binding protein 3 L homeolog (igf2bp3.L), 2610101N11Rik, AA522010, Ab2-255, AL022933, AU045931, B3, CT98, dvr1rbp, IGF2 mRNA-binding protein 3-A, igf2bp3-a, igf2bp3-b, IMP, IMP-3, imp-3, IMP-3-A, IMP3, imp3, KOC1, koc1, Koc13, mimp3, Neilsen, RGD1306512, vera, vera-A, Vg1 RBP-A, Vg1-RBP, vg1rbp, VICKZ3, vickz3, wu:fb79c12, wu:fe06h09, zVg1RBPBezeichner auf Proteinebene für IGF2BP3
- IGF II mRNA binding protein 3
- IGF-II mRNA-binding protein 3
- IGF2 mRNA-binding protein 3
- KH domain containing protein overexpressed in cancer
- KH domain-containing protein overexpressed in cancer
- VICKZ family member 3
- cancer/testis antigen 98
- hKOC
- insulin-like growth factor 2 mRNA-binding protein 3
- insulin-like growth factor 2, binding protein 3
- insulin-like growth factor 2 mRNA binding protein 3
- insulin-like growth factor 2 mRNA-binding protein 3-like
- mIMP-3
- IMP-3
- Vg1 RBP
- decapentaplegic and Vg-related 1 RNA-binding protein
- decapentaplegic and Vg-related 1, RNA binding protein
- vg1 RNA-binding protein
- vg1-RBP
- 69 kDa RNA-binding protein A
- IGF-II mRNA-binding protein 3-A
- IGF2 mRNA-binding protein 3-A
- IMP-3-A
- KH domain-containing transcription factor B3-A
- RNA-binding protein Vera-A
- Trans-acting factor B3-A
- VICKZ family member 3-A
- VLE-binding protein A
- Vg1 RNA binding protein Vera
- Vg1 RNA binding protein variant D
- Vg1 RNA-binding protein A
- Vg1 localization element binding protein A
- VgLE-binding and ER association protein A
- insulin-like growth factor 2 mRNA-binding protein 3-A
- trans-acting factor B3-A
- vg1 RBP-A
- vg1 RNA-binding protein A
- vg1 localization element binding protein A
- vgLE-binding and ER association protein A